These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 8529132)
1. Association of elevated protein kinase CK2 activity with aggressive behavior of squamous cell carcinoma of the head and neck. Gapany M; Faust RA; Tawfic S; Davis A; Adams GL; Ahmed K Mol Med; 1995 Sep; 1(6):659-66. PubMed ID: 8529132 [TBL] [Abstract][Full Text] [Related]
2. Elevated protein kinase CK2 activity in chromatin of head and neck tumors: association with malignant transformation. Faust RA; Gapany M; Tristani P; Davis A; Adams GL; Ahmed K Cancer Lett; 1996 Mar; 101(1):31-5. PubMed ID: 8625279 [TBL] [Abstract][Full Text] [Related]
3. Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells. Faust RA; Niehans G; Gapany M; Hoistad D; Knapp D; Cherwitz D; Davis A; Adams GL; Ahmed K Int J Biochem Cell Biol; 1999 Sep; 31(9):941-9. PubMed ID: 10533285 [TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides against protein kinase CK2-alpha inhibit growth of squamous cell carcinoma of the head and neck in vitro. Faust RA; Tawfic S; Davis AT; Bubash LA; Ahmed K Head Neck; 2000 Jul; 22(4):341-6. PubMed ID: 10862016 [TBL] [Abstract][Full Text] [Related]
5. Aurora kinase inhibition overcomes cetuximab resistance in squamous cell cancer of the head and neck. Hoellein A; Pickhard A; von Keitz F; Schoeffmann S; Piontek G; Rudelius M; Baumgart A; Wagenpfeil S; Peschel C; Dechow T; Bier H; Keller U Oncotarget; 2011 Aug; 2(8):599-609. PubMed ID: 21865609 [TBL] [Abstract][Full Text] [Related]
6. Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck. McCaffery JD; Gapany M; Faust RA; Davis AT; Adams GL; Ahmed K Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):283-8. PubMed ID: 9076234 [TBL] [Abstract][Full Text] [Related]
7. Association between phosphorylated AMP-activated protein kinase and acetyl-CoA carboxylase expression and outcome in patients with squamous cell carcinoma of the head and neck. Su YW; Lin YH; Pai MH; Lo AC; Lee YC; Fang IC; Lin J; Hsieh RK; Chang YF; Chen CL PLoS One; 2014; 9(4):e96183. PubMed ID: 24769813 [TBL] [Abstract][Full Text] [Related]
8. Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206 [TBL] [Abstract][Full Text] [Related]
10. Effects of the integrin-linked kinase inhibitor QLT0267 on squamous cell carcinoma of the head and neck. Younes MN; Yigitbasi OG; Yazici YD; Jasser SA; Bucana CD; El-Naggar AK; Mills GB; Myers JN Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):15-23. PubMed ID: 17224516 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase CK2 signal in neoplasia. Tawfic S; Yu S; Wang H; Faust R; Davis A; Ahmed K Histol Histopathol; 2001 Apr; 16(2):573-82. PubMed ID: 11332713 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta1 (TGFbeta1) expression in head and neck squamous cell carcinoma patients as related to prognosis. Logullo AF; Nonogaki S; Miguel RE; Kowalski LP; Nishimoto IN; Pasini FS; Federico MH; Brentani RR; Brentani MM J Oral Pathol Med; 2003 Mar; 32(3):139-45. PubMed ID: 12581383 [TBL] [Abstract][Full Text] [Related]
13. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Rubin Grandis J; Melhem MF; Barnes EL; Tweardy DJ Cancer; 1996 Sep; 78(6):1284-92. PubMed ID: 8826952 [TBL] [Abstract][Full Text] [Related]
14. Silmitasertib, a casein kinase 2 inhibitor, induces massive lipid droplet accumulation and nonapoptotic cell death in head and neck cancer cells. Su YW; Huang WY; Lin HC; Liao PN; Lin CY; Lin XY; Huang SH; Chen YT; Wu PS J Oral Pathol Med; 2023 Mar; 52(3):245-254. PubMed ID: 36273268 [TBL] [Abstract][Full Text] [Related]
15. Expression of a novel marker, Ubc9, in squamous cell carcinoma of the head and neck. Ronen O; Malone JP; Kay P; Bivens C; Hall K; Paruchuri LP; Mo YY; Robbins KT; Ran S Head Neck; 2009 Jul; 31(7):845-55. PubMed ID: 19309722 [TBL] [Abstract][Full Text] [Related]
16. High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer. Erpolat OP; Gocun PU; Akmansu M; Karakus E; Akyol G Strahlenther Onkol; 2012 Mar; 188(3):248-54. PubMed ID: 22311150 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implication of ERCC1 protein expression in resected oropharynx and oral cavity cancer. An HJ; Jo H; Jung CK; Kang JH; Kim MS; Sun DI; Cho KJ; Cho JH; Won HS; Sun S; Ko YH Pathol Res Pract; 2017 Aug; 213(8):949-955. PubMed ID: 28645807 [TBL] [Abstract][Full Text] [Related]
18. Elevated expression of T-lymphoma invasion and metastasis inducing factor 1 in squamous-cell carcinoma of the head and neck and its clinical significance. Wang S; Li S; Yang X; Yang S; Liu S; Liu B; Liu J Eur J Cancer; 2014 Jan; 50(2):379-87. PubMed ID: 24189000 [TBL] [Abstract][Full Text] [Related]
19. Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma. Kreycy N; Gotzian C; Fleming T; Flechtenmacher C; Grabe N; Plinkert P; Hess J; Zaoui K BMC Cancer; 2017 May; 17(1):382. PubMed ID: 28549423 [TBL] [Abstract][Full Text] [Related]
20. Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. Allende JE; Allende CC FASEB J; 1995 Mar; 9(5):313-23. PubMed ID: 7896000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]